Highlights

Share

Program Content

Activities

  • ClinicalThought: Emerging Treatment Options
    CROI 2021: Highlights From Data on Emerging Treatment Options
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2021

    Expires: April 05, 2022

  • HIV Prevention Data
    My Key Takeaways From Long-Acting PrEP Data Presented at CROI 2021
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 08, 2021

    Expires: April 07, 2022

  • Podcast: Virtual CROI 2021 – Rapid Recap
    Virtual CROI 2021 – Rapid Recap
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 18, 2021

    Expires: March 17, 2022

  • Slideset: CROI 2021
    Clinical Impact of New Data From CROI 2021
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 30, 2021

    Expires: March 29, 2022

Activities

GSK3640254 Phase IIa Trial
Novel, Next-Generation HIV-1 Maturation Inhibitor GSK3640254 Demonstrates Dose-Dependent Antiviral Response in Treatment-Naive Patients With HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2021

Expires: March 09, 2022

COVID-19 Racial Disparities in PWH
Racial Differences in COVID-19 Infection Rates Among PWH in the United States
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

HPTN 083: Incident Infections
HPTN 083: Incident Infections and Emergent Resistance in MSM and TGW Receiving Cabotegravir Long-Acting PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2021

Expires: March 09, 2022

COVID-19 in Pregnancy
COVID-19, But not HIV Infection, Is Associated With Increased Maternal Mortality in High-Risk Pregnancies Among South African Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

DolPHIN-2 Final Results
DolPHIN-2 Final Results: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Started in Late Pregnancy Through 72 Wks Postpartum
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2021

Expires: March 09, 2022

IMPAACT 2010 Update
IMPAACT 2010 Update: Comparable Safety and Efficacy With DTG + FTC/TAF or FTC/TDF vs EFV/FTC/TDF at 50 Wks Postpartum Following Initiation in Pregnancy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2021

Expires: March 10, 2022

ATLAS-2M Week 96 Results
ATLAS-2M, Wk 96 Results: Long-Acting Injectable Cabotegravir + Rilpivirine Every 8 Wks Is Noninferior to Every 4 Wks
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2021

Expires: March 10, 2022

REVAMP
REVAMP: Management Guided by Genotypic Resistance Testing Following First-line ART Failure Comparable to Viral Load–Guided Management in Sub-Saharan Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2021

Expires: March 07, 2022

Vascular Events in PWH on ART
Sex and Distinct Inflammation Pathways Predict Cardiovascular Disease and Vascular Events in Treated PWH
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2021

Expires: March 11, 2022

Prévenir Update
ANRS Prévenir: ANRS Prévenir: High Efficacy of Daily or On-Demand FTC/TDF PrEP Among Parisian MSM in Interim Analysis of Open-Label Prospective Cohort Study
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Gilead

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare